Medindia
To Take Care of Your Diabetes Click Here
Medindia » Patientinfo

Type 3c (Pancreatogenic) Diabetes

Medically Reviewed by The Medindia Medical Review Team on Nov 14, 2017


What is Type 3c (Pancreatogenic) Diabetes?

Pancreatogenic or type 3c diabetes mellitus is a form of secondary diabetes wherein the primary disease is in the exocrine portion of the pancreas and predates the development of diabetes.


It is suggested that between 5-10% of all diabetics may have pancreatogenic diabetes.

Interestingly nearly 80 percent of pancreatogenic diabetes is caused by chronic pancreatitis. The exact figures are not known as data remains scarce and frequently patients with pancreatic diabetes are misclassified.

Only recently have diagnostic criteria been proposed for pancreatogenic diabetes, enabling accurate diagnosis and appropriate management of the condition.

Pancreas - Overview of Structure and Function

The pancreas is an important organ found in the abdominal cavity. It is elongated and tapering and is situated behind the stomach. The pancreas is structurally divided into four parts namely head, neck body and tail.

Functionally, it is divided into two portions, the exocrine portion and the endocrine portion.

The endocrine portion of the pancreas (islets) secretes two important hormones directly into the bloodstream, namely insulin and glucagon. Both these hormones are important in carbohydrate metabolism and regulation of blood sugar levels.

Thus the pancreas is an important organ and diseases of the pancreas can have a serious impact on the health of an individual.

Common Diseases of the Pancreas

Types of Diabetes Mellitus

There are two main types of diabetes mellitus caused when the endocrine pancreas is affected.

Type 1 diabetes occurs when the insulin secreting cells (beta cells) in the islets are attacked by the body's immune system and destroyed. This results in absolute insulin deficiency.

In type 2 diabetes, the body becomes unresponsive and resistant to the effects of the insulin hormone. As a result more insulin needs to be released by the pancreas to bring down blood glucose levels. Over time the capacity of the beta cells to produce insulin is diminished.

A rare form of diabetes called pancreatic diabetes occurs when the disorder is primarily in the exocrine pancreas which predates the development of diabetes. It is also referred to as Type 3c diabetes. It is therefore a form of secondary diabetes because the primary pathology is NOT in the endocrine pancreas.

What are the Causes of Type 3c (Pancreatogenic) Diabetes?

Several disorders of the exocrine pancreas can cause pancreatogenic (type 3c) diabetes.


These include the following:

What are the Symptoms of Type 3c (Pancreatogenic) Diabetes?

Most patients with pancreatogenic type 3c diabetes have a history of chronic pancreatitis with exocrine pancreatic insufficiency characterized by abdominal pain, steatorrhea (increased fat in stools which float) or impaired digestion with nutritional deficiencies and glucose intolerance when there is endocrine involvement.

Some cases present with abdominal pain and indigestion without a history of pancreatitis.

Occasionally, only glucose intolerance may be evident with no features of pancreatic disease.

In later stages of the disease, with progressive loss of islet cells and decreased glucagon secretion as well, there may be frequent attacks of hypoglycemia (low blood sugar levels).

How do you Diagnose Type 3c (Pancreatogenic) Diabetes?

To improve the diagnosis of type 3c diabetes and reduce wrong misclassification of patients, Ewald and Bretzel proposed diagnostic criteria which include major and minor criteria. To make a diagnosis of type 3c diabetes, all three major criteria MUST be present.


The major criteria may be further supported by the presence of additional minor criteria such as

How do you Treat Type 3c (Pancreatogenic) Diabetes?

The primary target for the management of type 3c diabetes as with type 1 and type 2 remains control of hyperglycemia to achieve and maintain the HbA1c <7%, in order to minimize the risk of heart, kidney, eye and nerve related complications.

The various forms of management include:

Lifestyle modifications:

Quit smoking and alcohol since these contribute to increased inflammation of the pancreas and fibrosis. Maintain healthy weight since obesity decreases insulin sensitivity.

Nutritional Support

The chief aim of medical nutritional therapy in chronic pancreatitis-associated diabetes include the following:

In cystic fibrosis-related pancreatogenic diabetes (CFRD), the goals of therapy include:

Unlike other types of diabetes, salt and protein restriction is not recommended in CFRD, even in the background of arterial hypertension or microvessel complications.

Antihyperglycemic agents:

In chronic pancreatitis that is associated with mild diabetes, an oral antihyperglycemic agent, such as metformin, which improves insulin sensitivity may be considered. Oral anti-hyperglycemic agents are not useful in CFRD, as they are less effective than insulin in improving the metabolic or nutritional status of the patient.

Treatment with insulin is preferred in most patients, especially to correct hyperglycemia in CFRD, for severely malnourished, acutely ill or hospitalized patients, wherein the metabolic effects of insulin are especially beneficial for the patient.

Surgery:

Total pancreatectomy with islet autotransplantation is a surgical method employed in select patients to treat severe complications such as pain of recurrent acute and chronic pancreatitis with frequent hospitalizations, reducing the risk of severe diabetes mellitus and in persons with a high risk of pancreatic cancer.

Promising New Drugs

One of the emerging drugs that have shown great promise in the treatment of type 3c diabetes, secondary to chronic pancreatitis is pancreatic polypeptide (PP). It increases the expression of insulin receptors in the liver, thereby allowing better and more effective utilization of circulating insulin. It also enhances insulin sensitivity and reduces insulin requirements in type 3c diabetes patients.

How do you Prevent Type 3c (Pancreatogenic) Diabetes?

Pancreatogenic type 3c diabetes due to chronic pancreatitis may be prevented by reducing the risk factors of developing chronic pancreatitis. These include the following:

References:

  1. Type 3c (Pancreatogenic) Diabetes - (https://en.wikipedia.org/wiki/Type_3c_(Pancreatogenic)_Diabetes)
  2. Anatomy and Histology of the Pancreas - (https://www.pancreapedia.org/reviews/pancreatogenic-type-3c-diabetes)
  3. Pancreas: Anatomy and Functions - (https://www.hopkinsmedicine.org/healthlibrary/conditions/liver_biliary_and_pancreatic_disorders/pancreas_anatomy_and_functions_85,P00682)
  4. Management of pancreatogenic diabetes: challenges and solutions - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003514/)
  5. Pancreatogenic (Type 3c) Diabetes - (https://www.pancreapedia.org/reviews/anatomy-and-histology-of-pancreas)

Cite this Article

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dr. Lakshmi Venkataraman. (2017, November 14). Type 3c (Pancreatogenic) Diabetes - Causes, Symptoms, Diagnosis, Treatment & Prevention. Medindia. Retrieved on May 01, 2024 from https://www.medindia.net/health/conditions/type-3c-diabetes.htm.

  • MLA

    Dr. Lakshmi Venkataraman. "Type 3c (Pancreatogenic) Diabetes - Causes, Symptoms, Diagnosis, Treatment & Prevention". Medindia. May 01, 2024. <https://www.medindia.net/health/conditions/type-3c-diabetes.htm>.

  • Chicago

    Dr. Lakshmi Venkataraman. "Type 3c (Pancreatogenic) Diabetes - Causes, Symptoms, Diagnosis, Treatment & Prevention". Medindia. https://www.medindia.net/health/conditions/type-3c-diabetes.htm. (accessed May 01, 2024).

  • Harvard

    Dr. Lakshmi Venkataraman. 2017. Type 3c (Pancreatogenic) Diabetes - Causes, Symptoms, Diagnosis, Treatment & Prevention. Medindia, viewed May 01, 2024, https://www.medindia.net/health/conditions/type-3c-diabetes.htm.

View Non AMP Site | Back to top ↑